ReviewInternational journal of molecular sciences2022

Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology.

George J KontoghiorghesPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.